Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase III study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase III study

Published:2013-12 Issue:6 Volume:12 Page:607-616
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Zeng Meng-Su,Ye Hui-Yi,Guo Liang,Peng Wei-Jun,Lu Jian-Ping,Teng Gao-Jun,Huan Yi,Li Ping,Xu Jian-Rong,Liang Chang-Hong,Breuer Josy

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions;Hammerstingl;Eur Radiol,2008

2. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA;Zech;Magn Reson Med Sci,2007

3. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths;Rohrer;Invest Radiol,2005

4. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging;Hamm;Radiology,1995

5. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI;Weinmann;Magn Reson Med,1991

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gd-EOB-DTPA enhanced MRI is superior in selecting surgical candidates for patients with early-stage hepatocellular carcinoma: An analysis in terms of oncological outcomes;2023-10-23

2. Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer;Molecules;2023-10-10

3. Initial clinical experience with using a 1.5 Tesla MR-Linac for stereotactic body radiotherapy for cancer of the upper abdomen;2023-05-23

4. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition);Liver Cancer;2023

5. Hepatocellular carcinoma—An updated review;Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3